Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.10
-0.04 (-0.65%)
Jun 5, 2025, 10:19 AM - Market open

Aura Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Selling, General & Admin
23.2522.8119.7618.0610.094.16
Upgrade
Research & Development
79.5973.365.2342.2425.1618.04
Upgrade
Operating Expenses
102.8496.1284.9960.335.2522.21
Upgrade
Operating Income
-102.84-96.12-84.99-60.3-35.25-22.21
Upgrade
Interest Expense
------0
Upgrade
Interest & Investment Income
8.349.438.591.860.01-
Upgrade
Other Non Operating Income (Expenses)
-0.11-0.12-0.08-0.01-0.010
Upgrade
EBT Excluding Unusual Items
-94.61-86.81-76.48-58.45-35.25-22.21
Upgrade
Gain (Loss) on Sale of Assets
--0.21-0.32-0-
Upgrade
Pretax Income
-94.61-86.81-76.27-58.76-35.25-22.21
Upgrade
Income Tax Expense
0.080.110.14---
Upgrade
Net Income
-94.7-86.92-76.41-58.76-35.25-22.21
Upgrade
Preferred Dividends & Other Adjustments
----10.947.93
Upgrade
Net Income to Common
-94.7-86.92-76.41-58.76-46.19-30.13
Upgrade
Shares Outstanding (Basic)
5050403050
Upgrade
Shares Outstanding (Diluted)
5050403050
Upgrade
Shares Change (YoY)
17.12%25.32%32.34%480.18%1305.21%8.54%
Upgrade
EPS (Basic)
-1.90-1.75-1.93-1.96-8.95-82.06
Upgrade
EPS (Diluted)
-1.90-1.75-1.93-1.96-8.95-82.06
Upgrade
Free Cash Flow
-80.06-81.06-64.56-55.7-34.54-25.09
Upgrade
Free Cash Flow Per Share
-1.61-1.63-1.63-1.86-6.69-68.33
Upgrade
EBITDA
-101.63-94.89-83.7-59.12-34.42-21.38
Upgrade
D&A For EBITDA
1.211.221.31.180.830.83
Upgrade
EBIT
-102.84-96.12-84.99-60.3-35.25-22.21
Upgrade
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q